Biotinylated Canine PD-1 / PDCD1 Protein, His,Avitag™ (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
PD1-C52E5-25ug
$360.00
PD1-C52E5-200ug
$1420.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    PDCD1, PD1, CD279, SLEB2

  • Source

    Biotinylated Canine PD-1, His,Avitag (PD1-C52E5) is expressed from human 293 cells (HEK293). It contains AA Leu 25 - Gly 168 (Accession # NP_001301026.1).

    Predicted N-terminus: Leu 25

    Request for sequence
  • Molecular Characterization

    PD-1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 19.7 kDa. The protein migrates as 32-36 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    PD-1 SDS-PAGE

    Biotinylated Canine PD-1, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    PD-1 SEC-MALS

    The purity of Biotinylated Canine PD-1, His,Avitag (Cat. No. PD1-C52E5) is more than 85% and the molecular weight of this protein is around 27-40 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     PD-1 ELISA

    Immobilized Human PD-L1, Fc Tag (Cat. No. PD1-H5258) at 2 μg/mL (100 μL/well) can bind Biotinylated Canine PD-1, His,Avitag (Cat. No. PD1-C52E5) with a linear range of 1-63 ng/mL (QC tested).

    Protocol
  •  PD-1 ELISA

    Immobilized Biotinylated Canine PD-1, His,Avitag (Cat. No. PD1-C52E5) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Human PD-1 Antibody, Human IgG4 with a linear range of 0.004-1 μg/mL (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-γ secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.

Recent Advances

 
Drug Development Progress
  • English Name:

    Programmed cell death protein 1

  • Category:

  • Approved Drugs:

    22 Details

  • Drugs in Clinical Trials:

    193 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호